Abstract:
Prabhavathi Fernandes spent over three decades developing drugs for bacterial infections. On the brink of developing a treatment for pnemonia, Fernandes' Chapel Hill-based Cempra, Inc. was halted by federal regulators. Although Fernandes abruptly left the company, Cempra seeks to rebound.